Skip to main content
BIOTRON LIMITED logo

BIOTRON LIMITED — Investor Relations & Filings

Ticker · BIT ISIN · AU000000BIT4 ASX Professional, scientific and technical activities
Open in API
Filings indexed 765 across all filing types
Latest filing 2018-10-23 Share Issue/Capital Cha…
Country AU Australia
Listing ASX BIT

About BIOTRON LIMITED

https://www.biotron.com.au

Biotron Limited is a clinical-stage company focused on the development of novel small molecule antiviral therapeutics. The company utilizes its proprietary ViroPore technology platform to design and develop drugs that target viroporins—a class of proteins found in a wide range of viruses that play critical roles in viral replication and the evasion of host immune responses. Biotron's primary clinical program centers on BIT225, a first-in-class inhibitor targeting the HIV-1 Vpu protein and the Hepatitis C virus p7 protein. The company aims to address unmet medical needs by developing treatments that can potentially eradicate viral reservoirs and improve patient outcomes. In addition to HIV and HCV, Biotron is exploring the application of its antiviral platform against other significant viral pathogens, including SARS-CoV-2, leveraging its expertise in ion channel-targeting chemistry to disrupt the viral life cycle.

Recent filings

Filing Released Lang Actions
Appendix 3B 13 pages 1.0MB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3B form, which is a New Issue Announcement and Application for Quotation of Additional Securities submitted to the ASX (Australian Securities Exchange). It details the issuance of new fully paid ordinary shares, the number of securities issued, issue price, purpose of the issue, and compliance with ASX Listing Rules. The document is a regulatory announcement about new share issuance and quotation application, not a full financial report or earnings release. It is not a report itself but an official announcement of a capital raising event and securities issuance. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is substantial and contains detailed information about the share issue, consistent with an SHA filing rather than a brief announcement or a report publication announcement.
2018-10-23 English
Appointment of a Director and Appendix 3X 4 pages 33.0KB
Board/Management Information Classification · 100% confidence The document is an announcement from Biotron Limited regarding the appointment of a new director, Professor Stephen Locarnini. It includes biographical details, qualifications, and roles of the new director, as well as an Appendix 3X Initial Director's Interest Notice, which is a regulatory form related to director's share interests. The content focuses on management changes and director interests, with no financial statements or report data. Therefore, it fits the category of Board/Management Information (MANG). The document length and content confirm it is not a brief announcement or a report publication notice, but a substantive management change announcement.
2018-10-22 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B New Issue Announcement filed with the ASX, detailing the issuance of new fully paid ordinary shares following the exercise of options by the company's Managing Director. It includes detailed information about the securities issued, their terms, issue price, purpose, and compliance with ASX Listing Rules. The document is a formal announcement of a capital raising event through share issuance, specifically the exercise of options and subsequent quotation application for additional securities. It does not contain financial statements, management discussion, or audit information, nor is it a report or transcript. It is clearly a capital/financing update related to changes in the company's capital structure. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2018-10-22 English
Appendix 3B 13 pages 1.0MB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 3B form, which is a standard ASX (Australian Securities Exchange) form used for announcing new issues of securities and applying for quotation of additional securities. It includes detailed information about the class and number of securities issued, issue price, purpose of the issue, and compliance with ASX listing rules. The document is not a financial report, earnings release, or management discussion, but rather a regulatory announcement related to capital raising and share issuance. This fits the definition of a Capital/Financing Update (CAP) filing, as it updates on company fundraising and capital structure changes. The document length is substantial and contains detailed data, not just a brief announcement or a certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is CAP with high confidence.
2018-10-21 English
Annual Report and Notice of AGM 60 pages 7.8MB
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2018' and includes detailed sections typical of an annual report such as Operating and Financial Review, Corporate Governance Statement, Directors' Report, Auditor's Report, and full financial statements including Statement of Profit or Loss, Statement of Financial Position, and Notes to the Financial Statements. The document references the fiscal year ended 30 June 2018, which aligns with a full fiscal year reporting period. The length of the document (15,000 characters) and the presence of comprehensive financial data and management discussion confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K).
2018-10-17 English
Appendix 3B 13 pages 139.6KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard new issue announcement form used by companies listed on the Australian Securities Exchange (ASX) to notify the market of new securities being issued. It includes detailed information about the class and number of securities issued, issue price, purpose of the issue, and compliance with ASX listing rules. The document is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about a capital raising event (exercise of options and issuance of shares). This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising, financing activities, or capital structure changes. The document length and content confirm it is the announcement itself, not just a brief notice or a report publication announcement.
2018-10-17 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.